Clinical Trial Update: Study of Placental Vascularization Using Contrast Ultrasound [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating placental vascularization using contrast ultrasound for fetal growth restriction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Fetal Growth Restriction | Phase 3 | Status: RECRUITING